JPS6026493B2
(ja)
*
|
1980-01-29 |
1985-06-24 |
静岡大学長 |
ポリエーテルカーボネート
|
AU544564B2
(en)
*
|
1980-08-09 |
1985-06-06 |
Sato Shokuhin Kogyo Kabushiki Kaisha |
Extracting beverages using cyclodextrin
|
HU194858B
(en)
*
|
1982-12-03 |
1988-03-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
|
US4596795A
(en)
*
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
US4727064A
(en)
*
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
US6407079B1
(en)
*
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
US4920214A
(en)
*
|
1986-04-16 |
1990-04-24 |
American Maize-Products Company |
Process for producing modified cyclodextrins
|
IT1203968B
(it)
*
|
1987-04-24 |
1989-02-23 |
Bononi Ricerca |
Complessi di b-ciclodestrina ad attivita' antimicotica
|
US4877778A
(en)
*
|
1987-07-01 |
1989-10-31 |
The Children's Medical Center Corporation |
Method of enhancing lipophile transport using cyclodextrin derivatives
|
US5017566A
(en)
*
|
1987-12-30 |
1991-05-21 |
University Of Florida |
Redox systems for brain-targeted drug delivery
|
US5002935A
(en)
*
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
US4889634A
(en)
*
|
1988-10-04 |
1989-12-26 |
Gynex, Inc. |
Dialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using same
|
US5997856A
(en)
*
|
1988-10-05 |
1999-12-07 |
Chiron Corporation |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
|
AU616571B2
(en)
*
|
1988-10-28 |
1991-10-31 |
Shiseido Company Ltd. |
Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
|
US5096893A
(en)
*
|
1989-04-03 |
1992-03-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Regioselective substitutions in cyclodextrins
|
EP0465535B1
(fr)
*
|
1989-04-03 |
1998-06-03 |
Janssen Pharmaceutica N.V. |
Substitutions selectives par region dans des cyclodextrines
|
US5173481A
(en)
*
|
1989-04-03 |
1992-12-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Preparation of specifically substituted cyclodextrins
|
US5154738A
(en)
*
|
1989-09-12 |
1992-10-13 |
Advanced Separation Technologies, Inc. |
Chiral separation media
|
US5064944A
(en)
*
|
1989-09-12 |
1991-11-12 |
Advanced Separation Technologies Inc. |
Chiral separation media
|
US4948395A
(en)
*
|
1989-09-12 |
1990-08-14 |
Advanced Separations Technologies Inc. |
Chiral separation media
|
US5124154A
(en)
*
|
1990-06-12 |
1992-06-23 |
Insite Vision Incorporated |
Aminosteroids for ophthalmic use
|
US5238927A
(en)
*
|
1990-11-30 |
1993-08-24 |
Brown Nesbitt D |
Hydrolytic stabilizer for unstable organic ions
|
US5254541A
(en)
*
|
1991-11-15 |
1993-10-19 |
Merck Frosst Canada, Inc. |
(Quinolin-2-ylmethoxy)indole/cyclodextrin complex
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5324718A
(en)
*
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
US5684169A
(en)
*
|
1992-11-27 |
1997-11-04 |
Ensuiko Sugar Refining Co., Ltd. |
Cyclodextrin inclusion complex of taxol, and method for its production and its use
|
PH31594A
(en)
*
|
1993-09-30 |
1998-11-03 |
Janssen Pharmaceutica Nv |
Oral formulations on an antifungal.
|
US5593670A
(en)
*
|
1994-08-12 |
1997-01-14 |
The Proctor & Gamble Company |
Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
|
US5939060A
(en)
*
|
1994-08-12 |
1999-08-17 |
The Procter & Gamble Company |
Composition for reducing malodor impression on inanimate surfaces
|
US5670475A
(en)
*
|
1994-08-12 |
1997-09-23 |
The Procter & Gamble Company |
Composition for reducing malodor impression of inanimate surfaces
|
US5534165A
(en)
*
|
1994-08-12 |
1996-07-09 |
The Procter & Gamble Company |
Fabric treating composition containing beta-cyclodextrin and essentially free of perfume
|
US5578563A
(en)
*
|
1994-08-12 |
1996-11-26 |
The Procter & Gamble Company |
Composition for reducing malodor impression on inanimate surfaces
|
US5714137A
(en)
*
|
1994-08-12 |
1998-02-03 |
The Procter & Gamble Company |
Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
|
US5668097A
(en)
*
|
1994-08-12 |
1997-09-16 |
The Procter & Gamble Company |
Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
|
WO1996004940A1
(fr)
|
1994-08-12 |
1996-02-22 |
The Procter & Gamble Company |
Composition reduisant l'impression de mauvaise odeur sur les surfaces inanimees
|
US5663134A
(en)
*
|
1994-08-12 |
1997-09-02 |
The Procter & Gamble Company |
Composition for reducing malodor impression on inanimate surfaces
|
US5492615A
(en)
*
|
1994-11-22 |
1996-02-20 |
Learonal Inc. |
Cyclodextrin stabilization of organic metal finishing additives in aqueous metal treating baths
|
US5562917A
(en)
*
|
1994-12-23 |
1996-10-08 |
Pentech Pharmaceuticals, Inc. |
Transdermal administration of apomorphine
|
US5744154A
(en)
*
|
1995-09-06 |
1998-04-28 |
Laboratoire Chauvin S.A. |
Ready-to-use indomethacin-based eye lotion
|
EP0954326B2
(fr)
|
1996-04-19 |
2009-07-22 |
Grifols Inc. |
Procede d'inactivation de virus dans des proteines sanguines lyophilisees
|
UA57734C2
(uk)
*
|
1996-05-07 |
2003-07-15 |
Пфайзер Інк. |
Комплекси включення арилгетероциклічних солей
|
US5874067A
(en)
*
|
1996-10-24 |
1999-02-23 |
The Procter & Gamble Company |
Methods for controlling environmental odors on the body
|
US5897855A
(en)
*
|
1996-10-24 |
1999-04-27 |
The Procter & Gamble Company |
Methods and compositions for reducing body odor
|
US5911976A
(en)
*
|
1996-10-24 |
1999-06-15 |
The Procter & Gamble Company |
Compositions for reducing body odor
|
US5879666A
(en)
*
|
1996-10-24 |
1999-03-09 |
The Procter & Gamble Company |
Methods and compositions for reducing body odor
|
US5882638A
(en)
*
|
1996-10-24 |
1999-03-16 |
The Proctor & Gamble Company |
Methods using uncomplexed cyclodextrin solutions for controlling environmental odors
|
US5780020A
(en)
*
|
1996-10-28 |
1998-07-14 |
The Proctor & Gamble Company |
Methods and compositions for reducing body odor
|
US5885599A
(en)
*
|
1996-10-28 |
1999-03-23 |
The Procter & Gamble Company |
Methods and compositions for reducing body odors and excess moisture
|
US20060029653A1
(en)
|
1997-01-29 |
2006-02-09 |
Cronk Peter J |
Therapeutic delivery system
|
PT1052974E
(pt)
*
|
1998-02-05 |
2009-08-07 |
Novartis Ag |
Formulação farmacêutica contendo epotilona
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
US6194181B1
(en)
*
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
NZ511116A
(en)
|
1998-11-10 |
2003-08-29 |
Janssen Pharmaceutica Nv |
HIV replication inhibiting pyrimidines
|
US6358469B1
(en)
|
1998-12-01 |
2002-03-19 |
S. C. Johnson & Son, Inc. |
Odor eliminating aqueous formulation
|
AU776645B2
(en)
*
|
1999-03-31 |
2004-09-16 |
Janssen Pharmaceutica N.V. |
Pregelatinized starch in a controlled release formulation
|
EE200100575A
(et)
|
1999-05-04 |
2003-02-17 |
Janssen Pharmaceutica N.V. |
Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod
|
DE19928676A1
(de)
*
|
1999-06-23 |
2000-12-28 |
Basf Ag |
Polyisocyanat-Polyadditionsprodukte
|
DE19930553A1
(de)
*
|
1999-07-02 |
2001-01-11 |
Wacker Chemie Gmbh |
Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten
|
US6740713B1
(en)
|
1999-07-08 |
2004-05-25 |
Procter & Gamble Company |
Process for producing particles of amine reaction products
|
US6764986B1
(en)
|
1999-07-08 |
2004-07-20 |
Procter & Gamble Company |
Process for producing particles of amine reaction products
|
US6972276B1
(en)
|
1999-07-09 |
2005-12-06 |
Procter & Gamble Company |
Process for making amine compounds
|
US6716805B1
(en)
*
|
1999-09-27 |
2004-04-06 |
The Procter & Gamble Company |
Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting in easier cleaning and maintenance, improved surface appearance and/or hygiene under stress conditions such as no-rinse
|
CA2384307C
(fr)
|
1999-09-27 |
2009-06-02 |
The Procter & Gamble Company |
Compositions de nettoyage pour surfaces dures, tampons prehumidifies, procedes d'utilisation et articles comportant lesdites compositions, ou tampons et instructions d'emploi permettant un nettoyage et un entretien facilites, un aspect de la surface et/ou de l'hygiene ameliores dans des conditions d'urgence telles que le non-rincage
|
US20050133174A1
(en)
*
|
1999-09-27 |
2005-06-23 |
Gorley Ronald T. |
100% synthetic nonwoven wipes
|
US6479467B1
(en)
*
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
ATE414079T1
(de)
*
|
2000-03-01 |
2008-11-15 |
Janssen Pharmaceutica Nv |
2,4-disubstituierte thiazolyl derivate
|
CA2406562C
(fr)
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Pyrimidines et triazines inhibant la replication du vih
|
US20020169090A1
(en)
*
|
2000-07-19 |
2002-11-14 |
Foley Peter Robert |
Cleaning composition
|
CA2415308A1
(fr)
*
|
2000-07-19 |
2002-01-24 |
The Procter & Gamble Company |
Composition nettoyante pour surface dure contenant un parfum pour masquer les odeurs
|
US7645746B1
(en)
|
2000-11-13 |
2010-01-12 |
The Procter & Gamble Company |
Composition for reducing malodor impression on inanimate surfaces
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
US6962944B2
(en)
|
2001-07-31 |
2005-11-08 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
US7074824B2
(en)
*
|
2001-07-31 |
2006-07-11 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
WO2003015773A2
(fr)
|
2001-08-13 |
2003-02-27 |
Janssen Pharmaceutica N.V. |
Derives de thiazolyl 2-amino-4,5-trisubstitue
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
US7638522B2
(en)
*
|
2001-08-13 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
|
US8101629B2
(en)
*
|
2001-08-13 |
2012-01-24 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
|
CN100519527C
(zh)
|
2002-03-13 |
2009-07-29 |
詹森药业有限公司 |
组织蛋白去乙酰酶抑制剂
|
EA007099B1
(ru)
|
2002-03-13 |
2006-06-30 |
Янссен Фармацевтика Н. В. |
Сульфонилпроизводные в качестве ингибиторов гистон-деацетилазы
|
MXPA04009037A
(es)
*
|
2002-03-20 |
2005-01-25 |
Pharmacia Corp |
Formulacion de eplerenona de almacenamiento estable.
|
DE10215942A1
(de)
*
|
2002-04-11 |
2003-10-23 |
Bayer Ag |
Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat
|
AU2003241464A1
(en)
*
|
2002-05-17 |
2003-12-02 |
Eisai Co., Ltd. |
Compositions and methods using proton pump inhibitors
|
US20030224030A1
(en)
|
2002-05-23 |
2003-12-04 |
Hirotaka Uchiyama |
Methods and articles for reducing airborne particulates
|
US6710096B2
(en)
|
2002-07-22 |
2004-03-23 |
Basf Corporation |
Polyether polyol for foam applications
|
DK1529032T3
(da)
*
|
2002-08-09 |
2013-07-08 |
Janssen Pharmaceutica Nv |
Fremgangsmåder til fremstilling af 4-4-4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)aminobenzonitrill
|
KR20110132482A
(ko)
*
|
2003-02-07 |
2011-12-07 |
얀센 파마슈티카 엔.브이. |
Hiv 감염 예방용 피리미딘 유도체
|
CN1747941A
(zh)
|
2003-02-07 |
2006-03-15 |
詹森药业有限公司 |
抑制hiv的1,2,4-三嗪
|
CL2004000303A1
(es)
*
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
CN101912615B
(zh)
*
|
2003-03-28 |
2013-03-27 |
阿莱斯贸易有限公司 |
用于改善的经口和透粘膜输送的克拉屈滨制剂
|
DK2272503T3
(da)
*
|
2003-03-28 |
2013-05-21 |
Ares Trading Sa |
Orale formuleringer af cladribin
|
US7157446B2
(en)
|
2003-05-02 |
2007-01-02 |
Bristol Myers Squibb Company |
Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
|
DK3604537T3
(da)
|
2003-06-13 |
2022-02-28 |
Alnylam Europe Ag |
Dobbeltstrenget ribonukleinsyre med forøget effektivitet i en organisme
|
UA81305C2
(en)
|
2003-07-02 |
2007-12-25 |
Ares Trading Sa |
Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
|
WO2005011618A2
(fr)
*
|
2003-07-31 |
2005-02-10 |
Ivax Corporation |
Methodes de traitement de dysfonctionnements sexuels masculins et feminins
|
WO2005028479A2
(fr)
*
|
2003-09-25 |
2005-03-31 |
Janssen Pharmaceutica N.V. |
Derives de purine servant a inhiber la replication du vih
|
DK1691811T3
(da)
|
2003-12-11 |
2014-10-20 |
Sunovion Pharmaceuticals Inc |
Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
|
EP2388017B1
(fr)
|
2004-02-24 |
2014-12-24 |
The General Hospital Corporation |
Radiofluoration catalytique
|
US20050234018A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
US7674778B2
(en)
|
2004-04-30 |
2010-03-09 |
Alnylam Pharmaceuticals |
Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
|
US6969706B1
(en)
*
|
2004-05-12 |
2005-11-29 |
Allergan, Inc. |
Preserved pharmaceutical compositions comprising cyclodextrins
|
US7151121B2
(en)
*
|
2004-05-26 |
2006-12-19 |
Danisco A/S |
Polyurethane containing a polyol composition comprising a highly branched polysaccharide, mix and process for preparation thereof
|
RU2416606C2
(ru)
|
2004-06-17 |
2011-04-20 |
Инфинити Дискавери, Инк. |
Соединения и способы для ингибирования взаимодействия bcl белков с компонентами по связыванию
|
PL1781639T3
(pl)
*
|
2004-07-28 |
2012-07-31 |
Janssen Pharmaceutica Nv |
Podstawione pochodne indolilo-alkiloaminowe jako nowe inhibitory deacetylazy histonowej
|
US7923554B2
(en)
*
|
2004-08-10 |
2011-04-12 |
Janssen Pharmaceutica N.V. |
HIV inhibiting 1,2,4-triazin-6-one derivatives
|
AU2005288864B2
(en)
*
|
2004-09-30 |
2012-08-23 |
Janssen Sciences Ireland Uc |
HIV inhibiting 5-heterocyclyl pyrimidines
|
MX2007003796A
(es)
*
|
2004-09-30 |
2007-04-25 |
Tibotec Pharm Ltd |
Pirimidinas 5-sustituidas inhibidoras del virus de inmunodeficiencia humana.
|
CN101048410B
(zh)
|
2004-10-29 |
2010-06-23 |
泰博特克药品有限公司 |
抑制hiv的双环嘧啶衍生物
|
BRPI0607214B8
(pt)
|
2005-01-27 |
2021-05-25 |
Janssen R & D Ireland |
derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação
|
UA95604C2
(ru)
*
|
2005-02-18 |
2011-08-25 |
Сьёрфейс Лоджикс, Инк. |
Способ регулирования фармакокинетического и/или фармакодинамического свойства соединения
|
UA90502C2
(ru)
*
|
2005-02-18 |
2010-05-11 |
Сьёрфейс Лоджикс, Инк. |
Имидазотриазиноновые соединения и фармацевтическая композиция, которая их содержит
|
US20080214588A1
(en)
*
|
2005-03-04 |
2008-09-04 |
Herman Augustinus De Kock |
Hiv Inhibiting 2-(4-Cyanophenyl)-6-Hydroxylaminopyrimidines
|
WO2006124726A2
(fr)
*
|
2005-05-12 |
2006-11-23 |
The General Hospital Corporation |
Nouvelles compositions biotinylatees
|
EP1928464B1
(fr)
|
2005-09-30 |
2014-05-14 |
Lundbeck Inc. |
Nouvelle preparation a base de carbamazepine a administration par voie parenterale
|
US20100204178A1
(en)
*
|
2006-10-02 |
2010-08-12 |
James Cloyd |
Novel parenteral carbamazepine formulation
|
US20070098148A1
(en)
*
|
2005-10-14 |
2007-05-03 |
Sherman Kenneth N |
Aroma releasing patch on mobile telephones
|
ES2327972T3
(es)
*
|
2006-01-19 |
2009-11-05 |
Janssen Pharmaceutica, N.V. |
Derivados de aminofenil como nuevos inhibidores de histona deacetilasa.
|
EP1981875B1
(fr)
*
|
2006-01-19 |
2014-04-16 |
Janssen Pharmaceutica N.V. |
Dérivés substitués d'indolyl-alkyl-amine en tant qu'inhibiteurs de l'histone désacétylase
|
US8114876B2
(en)
|
2006-01-19 |
2012-02-14 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
WO2007113254A1
(fr)
|
2006-03-30 |
2007-10-11 |
Tibotec Pharmaceuticals Ltd. |
Pyrimidines à substitution 5-amido inhibant le vih
|
WO2007113256A1
(fr)
*
|
2006-03-30 |
2007-10-11 |
Tibotec Pharmaceuticals Ltd. |
Pyrimidines substituées 5-(hydroxyméthylène et aminométhylène) inhibant le vih
|
CN101522623B
(zh)
|
2006-08-03 |
2013-06-12 |
塔夫茨大学信托人 |
无潮红烟酸类似物和其使用方法
|
MX2009002195A
(es)
|
2006-08-30 |
2009-05-28 |
David William Smith |
Metodo para impartir una rigidez mono-axial o multi-axial a materiales extruidos y productos que resultan de los mismos.
|
EP1920785A1
(fr)
|
2006-11-07 |
2008-05-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
|
CA2674185C
(fr)
*
|
2006-12-29 |
2017-02-28 |
Tibotec Pharmaceuticals Ltd. |
Pymiridines substituees en 5,6, inhibitrices du vih
|
CN101573343B
(zh)
*
|
2006-12-29 |
2016-02-24 |
爱尔兰詹森科学公司 |
抑制人免疫缺陷病毒的6-取代的嘧啶
|
WO2008088816A1
(fr)
*
|
2007-01-18 |
2008-07-24 |
Pgxhealth, Llc |
Formulations de dérivé d'adénosine pour l'imagerie médicale
|
WO2009006262A1
(fr)
*
|
2007-06-28 |
2009-01-08 |
Buckman Laboratories International, Inc. |
Utilisation de cyclodextrines pour contrôler les odeurs dans des boues issues de la fabrication de papier, boue désodorisée et produits
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
US8845627B2
(en)
*
|
2008-08-22 |
2014-09-30 |
Boston Scientific Scimed, Inc. |
Regulating pressure to lower temperature in a cryotherapy balloon catheter
|
WO2010048586A1
(fr)
|
2008-10-24 |
2010-04-29 |
Avi Biopharma, Inc. |
Compositions à sauts d’exons multiples pour la dmd
|
UA102709C2
(uk)
|
2008-11-15 |
2013-08-12 |
Ріб-Екс Фармасьютікалз, Інк. |
Протимікробна композиція
|
EP2216394A1
(fr)
|
2009-01-30 |
2010-08-11 |
The Procter & Gamble Company |
Procédé pour parfumer des étoffes
|
US9701177B2
(en)
|
2009-04-02 |
2017-07-11 |
Henkel Ag & Co. Kgaa |
Ceramic coated automotive heat exchanger components
|
CN102712928B
(zh)
|
2009-11-13 |
2017-08-04 |
萨雷普塔治疗公司 |
反义抗病毒化合物及治疗流感病毒感染的方法
|
US9068185B2
(en)
|
2010-03-12 |
2015-06-30 |
Sarepta Therapeutics, Inc. |
Antisense modulation of nuclear hormone receptors
|
ES2816898T3
(es)
|
2010-05-13 |
2021-04-06 |
Sarepta Therapeutics Inc |
Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
|
CN103096895B
(zh)
|
2010-06-24 |
2016-06-01 |
塔夫茨大学信托人 |
烟酸模拟物及其使用的方法
|
WO2011163612A1
(fr)
|
2010-06-24 |
2011-12-29 |
Trustees Of Tufts College |
Mimétiques de niacine et leurs procédés d'utilisation
|
WO2012100142A2
(fr)
|
2011-01-20 |
2012-07-26 |
Cornell University |
Traitements de troubles rétiniens
|
CN103328014A
(zh)
|
2011-01-27 |
2013-09-25 |
奇华顿股份有限公司 |
组合物
|
WO2013012752A2
(fr)
|
2011-07-15 |
2013-01-24 |
Sarepta Therapeutics, Inc. |
Procédés et compositions pour manipulation de la traduction d'isoformes de protéines à partir de sites initiateurs alternatifs d'initiation
|
PT2788487T
(pt)
|
2011-12-08 |
2018-07-03 |
Sarepta Therapeutics Inc |
Análogos de oligonucleótido visando lmna humano
|
US20140357666A1
(en)
|
2011-12-23 |
2014-12-04 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
MX2014007729A
(es)
|
2011-12-23 |
2015-01-12 |
Novartis Ag |
Compuestos para inhibir la interaccion de bcl2 con los componentes de enlace.
|
JP2015503518A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Bcl2と結合相手の相互作用を阻害するための化合物
|
JP2015503519A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Bcl2と結合相手の相互作用を阻害するための化合物
|
US20140350014A1
(en)
|
2011-12-23 |
2014-11-27 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
PL3702374T3
(pl)
|
2012-02-15 |
2022-11-21 |
Cydex Pharmaceuticals, Inc. |
Sposób wytwarzania pochodnych cyklodekstryny
|
RU2747757C2
(ru)
|
2012-02-28 |
2021-05-13 |
Сидекс Фармасьютикалс, Инк. |
Композиции алкилированного циклодекстрина и способы их получения и применения
|
WO2013171642A1
(fr)
|
2012-05-15 |
2013-11-21 |
Novartis Ag |
Dérivés de benzamide pour inhiber l'activité d'abl1, d'abl2 et de bcr-abl2
|
US9315489B2
(en)
|
2012-05-15 |
2016-04-19 |
Novartis Ag |
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
|
BR112014026383B1
(pt)
|
2012-05-15 |
2020-11-17 |
Novartis Ag |
derivados de benzamida, seu uso, e composição farmacêutica
|
KR20150020169A
(ko)
|
2012-05-15 |
2015-02-25 |
노파르티스 아게 |
Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
|
CA2883130A1
(fr)
|
2012-08-31 |
2014-03-06 |
The General Hospital Corporation |
Complexes de biotine pour le traitement et le diagnostic de la maladie d'alzheimer
|
CN105073785B
(zh)
|
2012-10-22 |
2018-08-21 |
锡德克斯药物公司 |
烷基化环糊精组合物及其制备和使用方法
|
AU2013364158A1
(en)
|
2012-12-20 |
2015-07-09 |
Sarepta Therapeutics, Inc. |
Improved exon skipping compositions for treating muscular dystrophy
|
AU2014219283C1
(en)
|
2013-02-19 |
2016-10-27 |
Novartis Ag |
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
|
BR122020016865B1
(pt)
|
2013-03-14 |
2022-12-27 |
Sarepta Therapeutics, Inc. |
Oligonucleotídeo antisenso, composição farmacêutica compreendendo o mesmo e uso da dita composição para o tratamento de distrofia muscular de duchenne (dmd)
|
PL2970964T3
(pl)
|
2013-03-14 |
2019-06-28 |
Sarepta Therapeutics, Inc. |
Kompozycje pomijające eksony do leczenia dystrofii mięśniowej
|
CA2906812A1
(fr)
|
2013-03-15 |
2014-09-18 |
Sarepta Therapeutics, Inc. |
Compositions ameliorees pour le traitement de la dystrophie musculaire
|
CA2915445A1
(fr)
|
2013-07-19 |
2015-01-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Composition pharmaceutique aqueuse liquide contenant des derives de cyclodextrine etherifies conserves
|
WO2015022664A1
(fr)
|
2013-08-14 |
2015-02-19 |
Novartis Ag |
Composés et compositions utiles comme inhibiteurs de mek
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
WO2015022663A1
(fr)
|
2013-08-14 |
2015-02-19 |
Novartis Ag |
Composés et compositions utiles comme inhibiteurs de mek
|
US20150104348A1
(en)
|
2013-10-10 |
2015-04-16 |
The Iams Company |
Pet Deodorizing Composition
|
WO2015092634A1
(fr)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
Composés et compositions de 1,2,3,4-tétrahydroisoquinoléine en tant qu'antagonistes et agents de dégradation sélectifs des récepteurs des œstrogènes
|
JP6523303B2
(ja)
|
2014-01-17 |
2019-05-29 |
ノバルティス アーゲー |
Shp2の活性を阻害するための1−ピリダジン/トリアジン−3−イル−ピペラジン/ピペリジン/ピロリジン誘導体およびその組成物
|
JP6473457B2
(ja)
|
2014-01-17 |
2019-02-20 |
ノバルティス アーゲー |
Shp2の活性を阻害するための1−(トリアジン−3−イル/ピリダジン−3−イル)−ピペリジン/ピペラジン誘導体およびその組成物
|
JO3517B1
(ar)
|
2014-01-17 |
2020-07-05 |
Novartis Ag |
ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
|
EP3183295B1
(fr)
|
2014-08-22 |
2023-08-02 |
CyDex Pharmaceuticals, Inc. |
Compositions de cyclodextrine alkylée fractionnées et leurs procédés de préparation et d'utilisation
|
CN107250337A
(zh)
|
2014-12-23 |
2017-10-13 |
路博润先进材料公司 |
衣物洗涤剂组合物
|
JP2018502196A
(ja)
|
2014-12-23 |
2018-01-25 |
ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド |
両親媒性架橋剤と架橋した両親媒性レオロジー改変剤で安定化された洗濯洗剤組成物
|
ES2949850T3
(es)
|
2015-04-20 |
2023-10-03 |
Univ Cornell |
Materiales poliméricos de ciclodextrina porosa
|
JP6878316B2
(ja)
|
2015-06-19 |
2021-05-26 |
ノバルティス アーゲー |
Shp2の活性を阻害するための化合物および組成物
|
CN112625028A
(zh)
|
2015-06-19 |
2021-04-09 |
诺华股份有限公司 |
用于抑制shp2活性的化合物和组合物
|
EP3310779B1
(fr)
|
2015-06-19 |
2019-05-08 |
Novartis AG |
Composés et compositions pour l'inhibition de l'activité de shp2
|
EP3653216A1
(fr)
|
2015-09-30 |
2020-05-20 |
Sarepta Therapeutics, Inc. |
Procédés de traitement de la dystrophie musculaire
|
NZ747685A
(en)
|
2016-04-29 |
2023-05-26 |
Sarepta Therapeutics Inc |
Oligonucleotide analogues targeting human lmna
|
MX2018015625A
(es)
|
2016-06-14 |
2019-03-06 |
Novartis Ag |
Compuestos y composiciones para inhibir la actividad de shp2.
|
AU2017290231A1
(en)
|
2016-06-30 |
2019-02-07 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomers for muscular dystrophy
|
LT3494125T
(lt)
|
2016-08-02 |
2022-11-10 |
Virginia Commonwealth University |
Kompozicijos, apimančios 5-cholesteną-3, 25-diolį, 3-sulfatą (25hc3s) arba farmaciniu požiūriu priimtiną jo druską ir bent vieną ciklinį oligosacharidą
|
KR20230124756A
(ko)
|
2016-08-02 |
2023-08-25 |
버지니아 커먼웰스 유니버시티 |
염증성 피부 질환 및 피부 병변을 치료하기 위한 산소첨가된콜레스테롤 술페이트 (ocs) 의 용도
|
MX2019006989A
(es)
|
2016-12-19 |
2019-08-16 |
Sarepta Therapeutics Inc |
Conjugados de oligomeros de omision de exon para distrofia muscular.
|
BR112019012664A2
(pt)
|
2016-12-19 |
2020-01-21 |
Sarepta Therapeutics Inc |
conjugados de oligômero de salto de éxon para distrofia muscular
|
MD3554553T2
(ro)
|
2016-12-19 |
2022-10-31 |
Sarepta Therapeutics Inc |
Conjugați de oligomeri de omitere a exonului, pentru distrofie musculară
|
WO2018195338A1
(fr)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions et procédés pour le traitement d'inflammation pulmonaire
|
EP3635017B1
(fr)
|
2017-05-04 |
2021-07-07 |
Lubrizol Advanced Materials, Inc. |
Microgel activé double
|
EA201991450A1
(ru)
|
2017-09-22 |
2019-12-30 |
Сарепта Терапьютикс, Инк. |
Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
|
US20200254002A1
(en)
|
2017-09-28 |
2020-08-13 |
Sarepta Therapeutics, Inc. |
Combination therapies for treating muscular dystrophy
|
US20210145852A1
(en)
|
2017-09-28 |
2021-05-20 |
Sarepta Therapeutics, Inc. |
Combination Therapies for Treating Muscular Dystrophy
|
JP2020536060A
(ja)
|
2017-09-28 |
2020-12-10 |
サレプタ セラピューティクス, インコーポレイテッド |
筋ジストロフィーを処置するための併用療法
|
US10765760B2
(en)
|
2018-05-29 |
2020-09-08 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
EP3806868A4
(fr)
|
2018-06-13 |
2022-06-22 |
Sarepta Therapeutics, Inc. |
Oligomères induisant un saut d'exon pour la dystrophie musculaire
|
TW202020153A
(zh)
|
2018-07-27 |
2020-06-01 |
美商薩羅塔治療公司 |
用於肌肉萎縮症之外顯子跳躍寡聚物
|
EA202191601A1
(ru)
|
2018-12-13 |
2022-01-19 |
Сарепта Терапьютикс, Инк. |
Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
|
US11279774B2
(en)
|
2019-01-03 |
2022-03-22 |
Underdog Pharmaceuticals, Inc. |
Cyclodextrin dimers, compositions thereof, and uses thereof
|
US11001645B2
(en)
|
2019-02-14 |
2021-05-11 |
Cyclopure, Inc. |
Charge-bearing cyclodextrin polymeric materials and methods of making and using same
|
JP7403855B2
(ja)
|
2019-02-14 |
2023-12-25 |
サイクロピュア, インコーポレイテッド |
電荷を有するシクロデキストリンポリマー材料ならびにその製造法及び使用法
|
MX2021011498A
(es)
|
2019-03-28 |
2022-01-04 |
Sarepta Therapeutics Inc |
Metodos para tratar la distrofia muscular con casimersin.
|
US20220193246A1
(en)
|
2019-04-18 |
2022-06-23 |
Sarepta Therapeutics, Inc. |
Compositions for treating muscular dystrophy
|
US20220296633A1
(en)
|
2019-06-19 |
2022-09-22 |
Sarepta Therapeutics, Inc. |
Methods for treating muscular dystrophy
|
BR112022009597A2
(pt)
|
2019-11-19 |
2022-08-16 |
Lubrizol Advanced Mat Inc |
Polímeros de inibição de redeposição e composições detergentes que contêm os mesmos
|
CN114867831A
(zh)
|
2019-12-19 |
2022-08-05 |
路博润先进材料公司 |
再沉积抑制性聚合物和含有所述再沉积抑制性聚合物的洗涤剂组合物
|
EP4233837A1
(fr)
|
2022-02-24 |
2023-08-30 |
CellAct Pharma GmbH |
Compositions solides et orales de toniribate d'étoposide
|
WO2023178230A1
(fr)
|
2022-03-17 |
2023-09-21 |
Sarepta Therapeutics, Inc. |
Conjugués d'oligomère morpholino phosphorodiamidate
|
CN115322358A
(zh)
*
|
2022-08-18 |
2022-11-11 |
上海东大化学有限公司 |
基于环糊精的聚醚多元醇的合成方法
|
WO2024073570A1
(fr)
|
2022-09-28 |
2024-04-04 |
Altos Labs, Inc. |
Expression de facteurs de régénération dans des cellules âgées/sénescentes
|